|
|
| PCR. n (%) | |
|
| n (%) | Negatif. n = 89 | Positif. n = 41 |
| Sociodemographic characteristics | |||
| Gender |
|
|
|
| Woman | 39 (30.0) | 26 (29) | 13 (32) |
| Male | 91 (70.0) | 63 (71) | 28 (68) |
| Age |
|
|
|
| (m ± standard derivation) | 39.4 ± 13.0 | 38.5 ± 13.0 | 42.0 ± 13.0 |
| District |
|
|
|
| Makélékélé | 14 (10.7) | 4 (4) | 10 (24) |
| Bacongo | 3 (2.3) | 2 (2) | 1 (2) |
| Poto-Poto | 11 (8.5) | 9 (10) | 2 (5) |
| Moungali | 27 (20.7) | 20 (22) | 7 (17) |
| Ouenze | 11 (8.5) | 7 (8) | 4 (10) |
| Talangaï | 29 (22.3) | 18 (20) | 11 (27) |
| Mfilou | 11 (8.5) | 10 (11) | 1 (2) |
| Madibou | 7 (5.4) | 6 (7) | 1 (2) |
| Djiri | 17 (13.1) | 13 (15) | 4 (10) |
| Clinical characteristics | |||
| Presence of COVID-19 symptoms |
|
|
|
| Yes | 112 (86.2) | 77 (87) | 35 (85) |
| No | 18 (13.8) | 12 (13) | 6 (15) |
| Frequency of symptoms (n = 18) |
|
|
|
| Fever | 6 (15.0) | 3 (17) | 3 (14) |
| Cough | 6 (15.0) | 2 (11) | 4 (19) |
| Shortness of breath | 7 (18.0) | 1 (6) | 6 (29) |
| Sore throat | 1 (3.0) | 0 (0.0) | 1 (5) |
| Headache | 10 (26.0) | 3 (17) | 7 (53) |
| Muscles soreness | 9 (23.0) | 9 (50) | 0 (0) |